Skip to main content
Article
Doxepin and imipramine: Effect on catecholamine inhibition of ganglionic transmission
Life Sciences
  • J. B. Tehrani
  • G. V. Rossi
  • Frederick J. Goldstein, Philadelphia College of Osteopathic Medicine
Document Type
Article
Publication Date
1-1-1975
Abstract

Doxepin (DOX) and imipramine (IM) administered by close intra-arterial injection (25, 40 and 60 μg/kg) potentiated the inhibitory effect of norepinephrine (NE) on electrically-evoked postganglionic potentials in the superior cervical ganglion of the cat. Dose-response relationships indicated no significant difference between DOX and IM with regard to their effect on NE activity. Potentiation of dopamine (DA)-induced suppression of ganglionic transmission by DOX and IM (25, 40 and 60 μg/kg) was not as pronounced as the potentiation of NE activity by these two antidepressants. Significant potentiation of DA was evident only at the 40 and 60 μg/kg dose levels of DOX and IM. Dose-response relationships indicated that potentiation of DA by DOX was significantly greater than that produced by IM. © 1975.

Comments

This article was published in Federation proceedings, Volume 36, Issue 3.

Citation Information
J. B. Tehrani, G. V. Rossi and Frederick J. Goldstein. "Doxepin and imipramine: Effect on catecholamine inhibition of ganglionic transmission" Life Sciences Vol. 17 (1975) p. 257 - 262
Available at: http://works.bepress.com/frederick_goldstein/36/